UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	May 8, 2023

Accession Number:	0001140361-23-016747
Submission Type:	POS AM
CIK: 0001281895 Company Name: ROCKET PHARMACEUTICALS, INC. File Number: 333-267871